Singapore's AI push to aid pulmonary care

The Health Sciences Authority has granted pre-market approval for LungVision.

Singapore’s adoption of artificial intelligence (AI)-powered intraoperative imaging technologies for pulmonary care could strengthen its position as a regional leader in advanced healthcare, said GlobalData.

One key development is the Health Sciences Authority’s pre-market approval for Body Vision Medical’s LungVision, a solution that uses AI-guided navigation to create CT-like visuals during bronchoscopy.

This real-time mapping allows pulmonologists to accurately locate small nodules, including those previously difficult to reach.

“With lung cancer being one of the leading causes of cancer-related mortality worldwide, technologies that improve early detection can significantly impact patient survival rates,” said Divya Soni, Medical Devices Analyst at GlobalData.

Moreover, integration of AI into routine clinical practice could help advance precision medicine and strengthen its adoption in the region, Soni added.